{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:52:28Z","timestamp":1778597548449,"version":"3.51.4"},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T00:00:00Z","timestamp":1123804800000},"content-version":"vor","delay-in-days":2050,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2000,1]]},"abstract":"<jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> To determine the utility of an assay for high risk genital human papillomavirus (HPV) in cervical screening in Zimbabwe, Africa.<\/jats:p><jats:p><jats:bold>Design\n\t\t\t\t\t<\/jats:bold> Cross\u2010sectional study.<\/jats:p><jats:p><jats:bold>Setting\n\t\t\t\t\t<\/jats:bold> Harare, Zimbabwe.<\/jats:p><jats:p><jats:bold>Population\n\t\t\t\t\t<\/jats:bold> Zimbabwe women (<jats:styled-content><jats:italic>n<\/jats:italic>= 2140<\/jats:styled-content>), 25 to 55 years old, recruited in clinics in Chitungwiza and Greater Harare.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> Genital specimens were assessed for HPV, using the HPV DNA test Hybrid Capture II (probe B). Further assessment of the women was conducted using colposcopy and biopsy as indicated. High grade squamous intraepithelial lesions were diagnosed in 215 women. Colposcopy and\/or biopsy showed low grade lesions in 346 women.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> The overall prevalences were: 42.7% for HPV, 10% for high grade squamous intraepithelial lesions and 16% for low grade lesions. Prevalence for HPV decreased significantly with increase in age (<jats:styled-content><jats:italic>P<\/jats:italic> for trend &lt; 0.0001<\/jats:styled-content>) and increased significantly with increasing disease severity, from 35% in normal women, to 53% in women with low grade lesions and 81% in women with high grade lesions (<jats:styled-content><jats:italic>P<\/jats:italic> for trend &lt; 0.001<\/jats:styled-content>). In specimens positive for HPV, the amount was 14\u2010fold higher in women with high grade lesions compared with normal women. In screening for high grade lesions the assay for HPV had a sensitivity of 81% (CI 75%\u201386%); sensitivity for low grade lesions was 64% (CI 60%\u201368%). Specificity was 62% (CI 59%\u201364%) for high grade lesions and 65% (CI 62%\u201367%) for low grade lesions. The positive predictive value was 19% (CI 17%\u201322%) for high grade lesions and 39% (CI 36%\u201342%) for low grade lesions.<\/jats:p><jats:p><jats:bold>Conclusion\n\t\t\t\t\t<\/jats:bold> For high grade squamous intraepithelial lesions the sensitivity of the Hybrid Capture II HPV DNA test was high, but the specificity was relatively low. The test may therefore be most useful in conjunction with other screening tests.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2000.tb11576.x","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T10:44:55Z","timestamp":1123843495000},"page":"33-38","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe"],"prefix":"10.1111","volume":"107","author":[{"given":"Sharita D.","family":"Womack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. M.","family":"Chirenje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne","family":"Gaffikin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Chipato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ngwalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keerti V.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,12]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"519","article-title":"Cancer in Developing Countries","volume":"19","author":"Parkin DM","year":"1994","journal-title":"IARC; Cancer surveys: trends in cancer incidence and mortality"},{"key":"e_1_2_5_3_2","first-page":"290","article-title":"Trends in cervical cancer mortality in the Americas","volume":"30","author":"Robles SC","year":"1996","journal-title":"Bull PAHO"},{"key":"e_1_2_5_4_2","unstructured":"HakamaM MillerAB Day NE.Screening for cancer of the uterine cervix; IARC Scientific Publications No. 76;1986:161\u2013168."},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.0.CO;2-0"},{"key":"e_1_2_5_6_2","first-page":"42","article-title":"Plotting a new course for cervical screening in developing countries","volume":"8","author":"Stjernsward J","year":"1987","journal-title":"World Health Forum"},{"key":"e_1_2_5_7_2","first-page":"293","article-title":"Acetic acid visualization of the cervix to detect cervical dysplasia","volume":"81","author":"Le L","year":"1993","journal-title":"Obstet Gynecol"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(82)90642-1"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(96)00189-5"},{"key":"e_1_2_5_10_2","first-page":"796","article-title":"mavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer Study Group","volume":"87","year":"1995","journal-title":"mavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer Study Group"},{"key":"e_1_2_5_11_2","volume":"64","author":"International Agency for Research on Cancer.","year":"1995","journal-title":"IARC Monographs on the Evaluation of Carcinogenic Risk to Humans"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910520513"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90026-8"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(94)00373-L"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)91473-0"},{"key":"e_1_2_5_16_2","unstructured":"MeijerCJ van denBruleAJ SnijdersPJ HelmerhorstT KenemansP WalboomersJM.Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical screening.IARC Scientific Publications No. 119;1992:271\u2013281."},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91086-7"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)70602-6"},{"key":"e_1_2_5_19_2","first-page":"389","volume-title":"New Developments in Cervical Screening and Prevention","author":"Herrero R","year":"1997"},{"key":"e_1_2_5_20_2","volume-title":"17th International Papillomavirus Conference","author":"Lorincz AT","year":"1999"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90129-B"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910630107"},{"key":"e_1_2_5_23_2","first-page":"869","article-title":"University of Zimbabwe \/JHPIEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical screening: test qualities in a primary care setting","volume":"353","year":"1999","journal-title":"University of Zimbabwe \/JHPIEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical screening: test qualities in a primary care setting"},{"key":"e_1_2_5_24_2","first-page":"1","article-title":"Hybrid capture method for detection of human papillomavirus DNA in clinical specimens","volume":"7","author":"Lorincz A.","year":"1996","journal-title":"Papillomavirus Report"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","unstructured":"SchneiderA KoutskyLA Natural history and epidemiological features of genital HPV infection.IARC Scientific Publication No. 119;1992:25\u201352.","DOI":"10.1016\/0163-4453(92)92347-L"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(98)00006-4"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2000.tb11576.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2000.tb11576.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T12:25:15Z","timestamp":1697372715000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2000.tb11576.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1111\/j.1471-0528.2000.tb11576.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2000.tb11576.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]},"assertion":[{"value":"2005-08-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}